On 3 September 2020, IFPMA organised a media briefing on COVID-19 therapeutics: innovation, trials and access. The briefing included an overview of R&D for the COVID-19 therapeutics pipeline and how IFPMA member companies are collaborating to develop and deploy safe and effective treatments at scale.